Literature DB >> 27098064

Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case-control study and a meta-analysis.

Xiao-Lei Huang1, Guo-Cui Wu1, Yu-Jie Wang1, Xiao-Ke Yang1, Guo-Jun Yang2, Jin-Hui Tao2, Yu Duan1, Jun-Wei Yan1, Xiang-Pei Li2, Dong-Qing Ye3, Jing Wang4.   

Abstract

The aim of our study was to investigate the association of five single nucleotide polymorphisms in interleukin-1 (IL-1) gene with susceptibility to systemic sclerosis (SSc) in a Chinese population. A total of 58 SSc patients and 113 healthy controls were enrolled. TaqMan allele discrimination assay was performed to detect the genotyping of IL-1A -889C/T (rs1800587), IL-1B -511C/T (rs16944), IL-18 -607C/A (rs1946518), IL-18 -137G/C (rs187238) and IL-33 rs7044343. The association between these SNPs and SSc risk was analyzed. Furthermore, a meta-analysis of relevant studies on the association of IL-1A -889C/T (rs1800587) and IL-1B -511C/T (rs16944) with the susceptibility to SSc was performed. Through the genotyping, significant associations for SSc were found for: IL-1A -889C/T genotype frequencies (P = 0.000), dominant model (P = 0.000), recessive model (P = 0.001) and allele T frequency (P = 0.000). Among SSc patients, dyspnea was significantly associated with IL-18 -607C/A genotype frequency and IL-33 rs7044343 allele frequency (P = 0.037, P = 0.042, respectively). In addition, elevated erythrocyte sedimentation rate was significantly associated with IL-18 -137G/C (rs187238) genotype and allele frequency (P = 0.019, P = 0.006, respectively). While meta-analysis showed there was no significant association between IL-1A -889C/T polymorphism and SSc, for IL-1B -511C/T (rs16944), significant associations were found in the comparison of allele C versus T (OR 1.267, 95 % CI 1.016-1.580) by combined different outcomes. Results showed that IL-1A -889C/T (rs1800587) was associated with SSc susceptibility in the Chinese population. However, this association was not supported by a meta-analysis of all relevant studies. Further investigations are required to verify our findings.

Entities:  

Keywords:  Chinese population; Interleukin-1; Polymorphism; Systemic sclerosis

Mesh:

Substances:

Year:  2016        PMID: 27098064     DOI: 10.1007/s12026-016-8797-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  28 in total

1.  Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.

Authors:  Silvia Mattuzzi; Stefano Barbi; Antonio Carletto; Viviana Ravagnani; Patrick S Moore; Lisa Maria Bambara; Aldo Scarpa
Journal:  J Rheumatol       Date:  2007-04-15       Impact factor: 4.666

2.  Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement.

Authors:  Mirko Manetti; Serena Guiducci; Claudia Ceccarelli; Eloisa Romano; Silvia Bellando-Randone; Maria Letizia Conforti; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2011-05-12       Impact factor: 19.103

3.  The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.

Authors:  Masoumeh Heidary; Nahid Rakhshi; Majid Pahlevan Kakhki; Mehrdad Behmanesh; Mohammad Hossein Sanati; Nima Sanadgol; Hossein Kamaladini; Abbas Nikravesh
Journal:  J Neurol Sci       Date:  2014-05-15       Impact factor: 3.181

4.  Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Authors:  Koichi Yanaba; Ayumi Yoshizaki; Yoshihide Asano; Takafumi Kadono; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2011-01-19       Impact factor: 2.980

Review 5.  Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis.

Authors:  Inês Chora; Serena Guiducci; Mirko Manetti; Eloisa Romano; Celestina Mazzotta; Silvia Bellando-Randone; Lidia Ibba-Manneschi; Marco Matucci-Cerinic; Raquel Soares
Journal:  Autoimmun Rev       Date:  2014-12-06       Impact factor: 9.754

Review 6.  IL-18 in inflammatory and autoimmune disease.

Authors:  Saikiran K Sedimbi; Thomas Hägglöf; Mikael C I Karlsson
Journal:  Cell Mol Life Sci       Date:  2013-07-27       Impact factor: 9.261

7.  IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis.

Authors:  S Abtahi; A Farazmand; M Mahmoudi; A Ashraf-Ganjouei; A Javinani; B Nazari; H Kavosi; A A Amirzargar; A R Jamshidi; F Gharibdoost
Journal:  Int J Immunogenet       Date:  2015-09-28       Impact factor: 1.466

8.  Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population.

Authors:  Yasushi Kawaguchi; Akiko Tochimoto; Naomi Ichikawa; Masayoshi Harigai; Masako Hara; Shigeru Kotake; Yutaka Kitamura; Naoyuki Kamatani
Journal:  Arthritis Rheum       Date:  2003-01

9.  Regulation of matrix metalloproteinase-1 and alpha-smooth muscle actin expression by interleukin-1 alpha and tumour necrosis factor alpha in hepatic stellate cells.

Authors:  Asami Inoue; Kenichi Obayashi; Yuka Sonoda; Anna Nakamura; Takato Ueno; Satoru Kuhara; Kosuke Tashiro
Journal:  Cytotechnology       Date:  2016-01-29       Impact factor: 2.058

10.  Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice.

Authors:  Jae-Young Um; Hong-Kun Rim; Su-Jin Kim; Hye-Lin Kim; Seung-Heon Hong
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

View more
  5 in total

1.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.

Authors:  Liya Li; Honglin Zhu; Xiaoxia Zuo
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

Review 3.  The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis.

Authors:  Dan Xu; Rong Mu; Xiaofan Wei
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

4.  IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease.

Authors:  Antonio Giovanni Versace; Alessandra Bitto; Carmelo Ioppolo; Caterina Oriana Aragona; Daniela La Rosa; William Neal Roberts; Tommaso D'Angelo; Antonella Cinquegrani; Santa Cirmi; Natasha Irrera; Michele Navarra; Salvatore Corrao; Sebastiano Gangemi; Gianluca Bagnato
Journal:  Front Med (Lausanne)       Date:  2022-02-17

Review 5.  Role of Alarmins in the Pathogenesis of Systemic Sclerosis.

Authors:  Antonello Giovannetti; Elisabetta Straface; Edoardo Rosato; Marco Casciaro; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.